TUE guidance documents including new regulations on glucocorticoids In order to assist physicians and athletes, in the last few weeks, WADA published the following guidance documents on managing TUEs to include the new regulations on glucocorticoids: General document on glucocorticoids and TUEs Checklists for athletes and treating physicians on a number of medical conditions for which glucocorticoids may be used TUE Physician Guidelines for TUE Committees on how to evaluate TUE requests for glucocorticoids for different medical conditions Educational resources In addition to the guidance documents listed above, WADA has provided a number of educational resources as part of its Code Implementation Support Program (CISP), which can be accessed on the Agencys Anti-Doping Education and Learning Platform (ADEL)
by the FDA The previous FDA-approved maximum dose of semaglutide for weight loss was 2.4 mg weekly by injection (Wegovy) Rushing your dose increase can backfire
If you take birth control pills by mouth, talk to your healthcare provider before you use Zepbound
What people find is CoolSculpting in isolation, is great, but CoolSculpting + semaglutide is even more dramatic
Your doctor will discuss possible side effects and important safety information with you before prescribing Wegovy
BPC 157 reconstitution is a straightforward process, but it requires a disciplined, sterile, and patient approach
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
